Etaqualone (Aolan, Athinazone, Ethinazone) is a quinazolinone-class GABAergic and is a simple of methaqualone that was created in the 1960s and showcased chiefly in France and some other European nations. It has soothing, mesmerizing, muscle relaxant and focal sensory system depressant properties coming about because of its agonist action at the β-subtype of the GABAA receptor, and was utilized for the treatment of a sleeping disorder.
The measurements and impacts are accounted for to be like those of methaqualone, however shorter acting and somewhat more vulnerable. Average reports use somewhere in the range of 50 and 500 mg of etaqualone, contingent upon wanted impacts. Old pharmaceutical plans of Ethinazone were 350 mg tablets. Etaqualone is thought to act likewise to barbiturates and benzodiazepines by expanding the affectability of GABAA receptors. Recreational impacts incorporate happiness, unwinding, expanded amiability and sexuality, decrease of transient memory, and loss of coordination. Blend with different depressants has a potentiating impact and can cause overdose. Resilience to benzodiazepines or liquor will likewise decrease impacts.
Ethaqualone can be available as a free base, insoluble in water yet dissolvable in liquor and nonpolar solvents, or as a water-dissolvable hydrochloride salt which is about 85% as intense as the freebase by weight.
The most well-known course of organization of etaqualone is oral, yet grunting the salt or smoking the free base have additionally been accounted for.